Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

New on Charts:

We've added Splits, Dividends, Earnings, and Earnings Estimates! Click on individual events to unveil more details.

If you prefer a cleaner view, easily disable them in Settings.

LUMO | Lumos Pharma Inc

Index- P/E- EPS (ttm)-3.85 Insider Own41.64% Shs Outstand8.27M Perf Week19.78%
Market Cap26.44M Forward P/E- EPS next Y-3.96 Insider Trans-0.17% Shs Float4.63M Perf Month10.63%
Income-31.77M PEG- EPS next Q-1.15 Inst Own24.38% Short Float / Ratio5.07% / 12.79 Perf Quarter5.05%
Sales2.23M P/S11.86 EPS this Y-9.43% Inst Trans7.55% Short Interest0.23M Perf Half Y-1.48%
Book/sh5.43 P/B0.61 EPS next Y2.56% ROA-44.81% Target Price20.20 Perf Year-63.00%
Cash/sh6.40 P/C0.52 EPS next 5Y15.20% ROE-53.76% 52W Range2.63 - 9.53 Perf YTD-7.76%
Dividend- P/FCF- EPS past 5Y29.09% ROI-63.77% 52W High-65.06% Beta0.86
Dividend %- Quick Ratio8.55 Sales past 5Y88.51% Gross Margin- 52W Low26.62% ATR0.23
Employees32 Current Ratio8.55 Sales Q/Q30.77% Oper. Margin-1529.55% RSI (14)56.04 Volatility10.48% 7.29%
OptionableNo Debt/Eq0.15 EPS Q/Q-16.67% Profit Margin-1426.81% Rel Volume0.03 Prev Close3.48
ShortableYes LT Debt/Eq0.14 EarningsAug 09 AMC Payout- Avg Volume18.36K Price3.33
Recom1.00 SMA205.80% SMA508.10% SMA200-1.59% Volume106 Change-4.31%
Date Action Analyst Rating Change Price Target Change
Mar-11-21Upgrade Stifel Hold → Buy $4 → $24
Dec-03-20Initiated Cantor Fitzgerald Buy $32
Aug-26-20Initiated Piper Sandler Overweight $26
Aug-17-20Resumed ROTH Capital Buy $51
Aug-04-20Initiated H.C. Wainwright Buy $33
Sep-26-23 09:00AM
Sep-14-23 08:00AM
Sep-07-23 04:34PM
Aug-22-23 09:00AM
Aug-09-23 04:01PM
09:00AM Loading…
Jul-26-23 09:00AM
Jul-12-23 08:00AM
Jun-28-23 04:01PM
Jun-21-23 09:00AM
May-31-23 08:00AM
May-25-23 08:00AM
May-22-23 09:00AM
May-08-23 08:00AM
May-03-23 04:05PM
Apr-27-23 09:00AM
09:00AM Loading…
Apr-19-23 09:00AM
Mar-09-23 04:05PM
Mar-05-23 02:00PM
Mar-01-23 04:05PM
Feb-28-23 04:05PM
Feb-15-23 04:05PM
Jan-03-23 09:00AM
Dec-12-22 07:30AM
Nov-29-22 04:05PM
Nov-22-22 04:05PM
Nov-14-22 06:10AM
Sep-26-22 04:05PM
Aug-31-22 09:00AM
Aug-16-22 07:30AM
04:01PM Loading…
Aug-09-22 04:01PM
Jul-27-22 04:05PM
Jul-24-22 08:27AM
Jul-20-22 08:32PM
May-16-22 04:05PM
May-10-22 04:01PM
May-06-22 10:25AM
May-05-22 09:00AM
Apr-26-22 09:00AM
Apr-11-22 08:30AM
Mar-23-22 04:05PM
Mar-10-22 04:01PM
Feb-23-22 09:00AM
Feb-14-22 12:05PM
Jan-05-22 09:00AM
Dec-28-21 09:38AM
Dec-21-21 09:38AM
Dec-16-21 09:38AM
Dec-08-21 09:38AM
Nov-24-21 10:00AM
Nov-15-21 11:14AM
Nov-10-21 05:06PM
Nov-08-21 10:42AM
Nov-03-21 04:01PM
Oct-21-21 04:05PM
Sep-02-21 08:00AM
Aug-16-21 09:58AM
Aug-05-21 08:00AM
Aug-03-21 08:00AM
Aug-02-21 08:00AM
Jul-26-21 04:18PM
Jul-22-21 08:00AM
Jul-20-21 04:01PM
Jun-28-21 08:00AM
May-19-21 09:00AM
May-13-21 09:00AM
May-05-21 04:01PM
Apr-28-21 09:00AM
Apr-27-21 08:00AM
Apr-20-21 04:05PM
Apr-14-21 04:05PM
Mar-20-21 11:00AM
Mar-11-21 04:05PM
Mar-09-21 04:05PM
Mar-04-21 09:00AM
Mar-02-21 04:05PM
Feb-22-21 04:15PM
Feb-16-21 04:01PM
Dec-18-20 09:00AM
Dec-16-20 02:19AM
Nov-30-20 05:35PM
Nov-23-20 07:43PM
Nov-10-20 04:01PM
Nov-03-20 12:30PM
Oct-29-20 09:00AM
Oct-27-20 04:01PM
Aug-27-20 09:00AM
Aug-13-20 04:01PM
Jul-28-20 04:01PM
Jul-27-20 04:05PM
Jun-19-20 08:21AM
Jun-10-20 03:41PM
May-28-20 04:01PM
May-27-20 04:27PM
May-26-20 10:36AM
Lumos Pharma, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics for rare diseases. Its product includes LUM-201, an oral growth hormone stimulating small molecule for the treatment of pediatric growth hormone deficiency (PGHD). The company was founded on June 4, 1999 and is headquartered in Austin, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
McKew John C.Chief Scientific OfficerAug 02Sale3.213,40710,91918,707Aug 03 04:58 PM
McKew John C.Chief Scientific OfficerApr 04Sale3.272,2147,24023,207Apr 04 05:22 PM
McKew John C.Chief Scientific OfficerFeb 02Sale3.534391,55026,457Feb 03 05:03 PM
McCracken Joseph SDirectorNov 16Buy5.034,00020,12015,721Nov 18 04:31 PM